Mother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in Botswana
Background:
A large-scale evaluation of mother-to-child transmission (MTCT) with dolutegravir (DTG)-based antiretroviral treatment (ART) has not been conducted previously.
Setting:
Botswana was the first African country to change from efavirenz (EFV)/tenofovir (TDF)/emtricitabine (FTC) to DTG/TDF/FTC first-line ART.
Methods:
From April 2015 to July 2018, the Early Infant Treatment Study offered HIV DNA testing at
Source: JAIDS Journal of Acquired Immune Deficiency Syndromes - Category: Infectious Diseases Tags: Rapid Communication Source Type: research
More News: African Health | Botswana Health | Children | Infectious Diseases | Study | Truvada | Viread